Zimmer Biomet Holdings, Inc. ZBH

91.04 1.35 1.51% as of 25 Sep
Market cap
$17.1B
P/E
22.0×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Zimmer Biomet Holdings, Inc. (ZBH) Operating margin

Zimmer Biomet Holdings, Inc.'s operating margin over the twelve months to 30 June 2026 was 14.2%, up 0.8 percentage points from fiscal 2025 (13.3%). Over the past ten years it has ranged from 0.43% (fiscal 2018) to 17.3% (fiscal 2023); the current reading is higher than 73% of that period. That is above the Medical Devices industry median of −15.0% and above the Healthcare sector median of 0.00%.

Operating margin, annual

Annual

Period Operating margin Change (points)
FY2025 13.3% (3.40)
FY2024 16.7% (0.54)
FY2023 17.3% 7.25
FY2022 10.0% (2.57)
FY2021 12.6% 11.24
FY2020 1.36% (12.89)
FY2019 14.3% 13.82
FY2018 0.43% (9.81)
FY2017 10.2% (0.47)
FY2016 10.7% 2.92

Quarterly

Period Operating margin Change (points)
Jun 2026 15.0% (2.90)
Mar 2026 17.9% 10.99
Dec 2025 6.89% (10.66)
Sep 2025 17.6% 3.11
42 more quarters

Against its own ten years

Low 0.43% High 17.3%
Ten-year median 10.7%
Current reading's percentile 73

Operating margin against peers

Company Operating margin
GMED Globus Medical, Inc. compare 20.3%
STE STERIS plc compare 18.9%
ZBH Zimmer Biomet Holdings, Inc. 14.2%
GEHC GE HealthCare Technologies Inc. compare 12.9%
PEN Penumbra, Inc. compare 12.5%
PHG Koninklijke Philips N.V. compare 9.64%
BIO Bio-Rad Laboratories, Inc. compare 2.05%
BIO.B Bio-Rad Laboratories, Inc. compare 2.05%
SNN Smith & Nephew SNATS, Inc. compare 0.00%
Medical Devices industry median −15.0%
Healthcare sector median 0.00%
Market median 0.00%

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on ZBH